Clinical TrialsSearch results
Number of results: 331
Recruiting
- CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease
- Breast Cancer, Early Breast Cancer
- Hibi Kazushige
- 2023-11-11
Recruiting
- An Expanded Access Program for belantamab mafodotin in Patients with Relapsed/Refractory Multiple Myeloma
- Multiple Myeloma
- Ishibashi Hideyasu
- 2022-02-15
Recruiting
- A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers (HERIZON-GEA-01)
- advanced or metastatic GEA, including gastric, GEJ, and esophageal adenocarcinomas.
- Sakanishi Ryuichi
- 2023-06-19
Recruiting
- A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy
- Breast Cancer
- Inoguchi Akihiro
- 2022-06-09
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01
Recruiting
- A Phase III, Randomised, Double-blind, Placebo-controlled, Multicentre, International Study of Durvalumab Plus Domvanalimab(AB154) in Participants With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer Whose Disease Has Not Progressed Following Definitive Platinum-based Concurrent Chemoradiation Therapy
- Non-Small Cell Lung Cancer
- Yamaji Shigeyuki
- 2022-03-23
Recruiting
- A phase II randomized trial of adjuvant chemotherapy for the patients completely resected pathological stage IB(T>5cm), II, IIIA Non Small Cell Lung Cancer comparing S-1 / S-1 with CDDP
- non-small cell lung cancer
- Kyushu University,Graduate School of Medical Science,Department of Surgery and Science
- 2009-03-12
Recruiting
- A Phase I, Open label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti tumor Effects of Recombinant Oncolytic Virus M1 (M1 c6v1) for Treatment of Patients with Locally Advanced or Metastatic Solid Tumors
- Solid Tumors
- Sawai Yoshihito
- 2023-12-15
Not yet recruiting
- Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 5)
- Multiple Myeloma
- Ishibashi Hideyasu
- 2023-09-12
Not yet recruiting
- Pan-tumor Study of I-DXd in Subjects with Recurrent or Metastatic Solid Tumors
- EC; HNSCC; PDAC; CRC; HCC ; Ad-eso/GEJ/Gastric; Non-squamous NSCLC; UC
- Inoguchi Akihiro
- 2024-04-05